高容量の赤血球造血刺激因子製剤が必要な血液透析患者に対するL-カルニチン補充療法の効果（赤血球寿命への効果も含めて）
作者： Takashi Mizuguchi , Chiharu Hojo , Kyoko Kanayama , Sachi Takaishi , Kazumi Okada
DOI: 10.4009/JSDT.47.191
关键词: Family medicine 、 Medicine
摘要:
sci-hub.st 参考文章(19)
A Arduini, G Mancinelli, G.L. Radatti, S Dottori, F Molajoni, R.R. Ramsay, Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty acid turnover in intact human erythrocytes. Journal of Biological Chemistry. ,vol. 267, pp. 12673- 12681 ,(1992) , 10.1016/S0021-9258(18)42330-7
Masami Matsumura, Syuichi Hatakeyama, Ichiro Koni, Hiroshi Mabuchi, Effect of L-carnitine and palmitoyl-L-carnitine on erythroid colony formation in fetal mouse liver cell culture American Journal of Nephrology. ,vol. 18, pp. 355- 358 ,(1998) , 10.1159/000013376
Thomas A. Golper, Marsha Wolfson, Suhail Ahmad, Raimund Hirschberg, Paul Kurtin, Lois Anne Katz, Robert Nicora, Don Ashbrook, Joel D. Kopple, Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects Kidney International. ,vol. 38, pp. 904- 911 ,(1990) , 10.1038/KI.1990.289
Kevin Stefanik, Dennis J. Cotter, Mae Thamer, James Kaufman, Yi Zhang, Epoetin requirements predict mortality in hemodialysis patients American Journal of Kidney Diseases. ,vol. 44, pp. 866- 876 ,(2004) , 10.1053/J.AJKD.2004.08.002
David E. Leaf, David S. Goldfarb, Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia Kidney International. ,vol. 75, pp. 15- 24 ,(2009) , 10.1038/KI.2008.414
Bruce M. Robinson, Marshall M. Joffe, Jeffrey S. Berns, Ronald L. Pisoni, Friedrich K. Port, Harold I. Feldman, Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney International. ,vol. 68, pp. 2323- 2330 ,(2005) , 10.1111/J.1523-1755.2005.00693.X
Shingo Fukuma, Takuhiro Yamaguchi, Seiji Hashimoto, Shigeru Nakai, Kunitoshi Iseki, Yoshiharu Tsubakihara, Shunichi Fukuhara, Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan American Journal of Kidney Diseases. ,vol. 59, pp. 108- 116 ,(2012) , 10.1053/J.AJKD.2011.07.014
Walter Dario Labonia, l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin American Journal of Kidney Diseases. ,vol. 26, pp. 757- 764 ,(1995) , 10.1016/0272-6386(95)90439-5
William R. Hiatt, Brian J. Koziol, Joseph I. Shapiro, Eric P. Brass, Carnitine metabolism during exercise in patients on chronic hemodialysis Kidney International. ,vol. 41, pp. 1613- 1619 ,(1992) , 10.1038/KI.1992.233
Mario Bonomini, Victor Zammit, Charles D. Pusey, Amedeo De Vecchi, Arduino Arduini, Pharmacological use of l-carnitine in uremic anemia: Has its full potential been exploited?☆ Pharmacological Research. ,vol. 63, pp. 157- 164 ,(2011) , 10.1016/J.PHRS.2010.11.006